Similar Articles
2111 Hepatic clearance measured with 99mTc-GSA single-photon emission computed tomography to estimate liver fibrosis
2112 Management of “very early” hepatocellular carcinoma on cirrhotic patients
2113 Mammalian target of rapamycin inhibition in hepatocellular carcinoma
2114 Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis
2115 Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma
2116 Metabolic syndrome in the development and progression of prostate cancer
2117 Metabolic syndrome and lower urinary tract symptoms
2118 Alcohol and hepatocellular carcinoma: A review and a point of view
2119 CYP2C19 polymorphism influences Helicobacter pylori eradication
2120 Gut microbiota and metabolic syndrome
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA